Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Cysview(TM) (Hexaminolevulinate HCL) Approved by the FDA for Cystoscopic Detection of Papillary Bladder Cancer
Cysview(TM) (Hexaminolevulinate HCL) Approved by the FDA for Cystoscopic Detection of Papillary Bladder Cancer
Cysview(TM) (Hexaminolevulinate HCL) Approved by the FDA for Cystoscopic Detection of Papillary Bladder Cancer
Submitted by
admin
on May 29, 2010 - 9:51am
Source:
PR Newswire
News Tags:
bladder cancer
Cysview
FDA
GE Healthcare
Headline:
Cysview(TM) (Hexaminolevulinate HCL) Approved by the FDA for Cystoscopic Detection of Papillary Bladder Cancer
Do Not Allow Advertisers to Use My Personal information
